Filed: 8/14/2026ACC: 0000919574-26-005163
📋 What this filing means
BROADWOOD CAPITAL INC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $1.91B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$1.91B
Total AUM (reported)
87.65M
Total Shares
Allocation by class
COM$1.23B64.5%
COM PAR $0.01$462.59M24.2%
RUSSELL 2000 ETF$142.69M7.5%
COM NEW$74.84M3.9%
Portfolio Concentration
Top 3$1.63B85.2%
4–10$282.46M14.8%
Top 3 weight
85.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 87.65M
Sole
Full voting authority
87.65M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other6
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
MONSTER BEVERAGE CORP NEW
DFNDShares8.11M
TypeSH
Market value$779.32M
40.73%
Sole
8.11M
Shared
0.00
None
0.00
STAAR SURGICAL CO
DFNDShares16.12M
TypeSH
Market value$462.59M
24.18%
Sole
16.12M
Shared
0.00
None
0.00
AXON ENTERPRISE INC
DFNDShares693.50K
TypeSH
Market value$388.79M
20.32%
Sole
693.50K
Shared
0.00
None
0.00
ISHARES TR
DFNDShares474.92K
TypeSH
Market value$142.69M
7.46%
Sole
474.92K
Shared
0.00
None
0.00
INSIGHT MOLECULAR DIA INC
DFNDShares12.68M
TypeSH
Market value$74.84M
3.91%
Sole
12.68M
Shared
0.00
None
0.00
LINEAGE CELL THERAPEUTICS IN
DFNDShares49.56M
TypeSH
Market value$64.92M
3.39%
Sole
49.56M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MONSTER BEVERAGE CORP NEWDFND | COM | 8.11M | SH | $779.32M 40.73% | 8.11M | 0.00 | 0.00 |
STAAR SURGICAL CODFND | COM PAR $0.01 | 16.12M | SH | $462.59M 24.18% | 16.12M | 0.00 | 0.00 |
AXON ENTERPRISE INCDFND | COM | 693.50K | SH | $388.79M 20.32% | 693.50K | 0.00 | 0.00 |
ISHARES TRDFND | RUSSELL 2000 ETF | 474.92K | SH | $142.69M 7.46% | 474.92K | 0.00 | 0.00 |
INSIGHT MOLECULAR DIA INCDFND | COM NEW | 12.68M | SH | $74.84M 3.91% | 12.68M | 0.00 | 0.00 |
LINEAGE CELL THERAPEUTICS INDFND | COM | 49.56M | SH | $64.92M 3.39% | 49.56M | 0.00 | 0.00 |